Published in Int J Cancer Clin Res on May 25, 2015
The most important questions in cancer research and clinical oncology-Question 2-5. Obesity-related cancers: more questions than answers. Chin J Cancer (2017) 1.33
Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes. Breast Cancer Res (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Modeling and variable selection in epidemiologic analysis. Am J Public Health (1989) 15.62
Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief (2012) 10.88
DNA methylation in cancer: too much, but also too little. Oncogene (2002) 6.96
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn (2006) 4.68
CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res (1999) 3.66
An overview of relations among causal modelling methods. Int J Epidemiol (2002) 3.32
Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst (2012) 2.77
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res (2000) 2.73
The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat (2002) 2.71
Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res (2011) 2.58
Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology (2009) 2.57
Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev (1994) 2.26
Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm (2010) 2.18
Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res (2001) 2.18
Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev (2001) 2.12
Obesity and cancer. Proc Nutr Soc (2008) 2.00
Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res (1998) 1.91
Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol (2003) 1.79
Obesity and breast cancer: a review of the literature. Breast (2004) 1.67
Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med (2000) 1.60
Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res (2001) 1.52
Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects. Breast Cancer Res Treat (2010) 1.46
Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. Am J Epidemiol (2005) 1.46
Data-based approach for developing a physical activity frequency questionnaire. Am J Epidemiol (1998) 1.45
Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res (2009) 1.37
Lifetime reproductive and anthropometric risk factors for breast cancer in postmenopausal women. Breast Dis (2006) 1.33
Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Carcinogenesis (2012) 1.26
Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Res Treat (2011) 1.22
Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis. Arch Environ Health (2004) 1.21
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer (2001) 1.21
Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2004) 1.17
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat (2008) 1.16
Case-control study of lifetime physical activity and breast cancer risk. Am J Epidemiol (2001) 1.15
Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer (2010) 1.14
GSTP1 promoter hypermethylation is an early event in breast carcinogenesis. Virchows Arch (2007) 1.05
TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity (Silver Spring) (2009) 1.03
Fat or fit: the joint effects of physical activity, weight gain, and body size on breast cancer risk. Cancer (2012) 1.02
Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI rats. Carcinogenesis (2009) 0.98
Gene promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat (2009) 0.97
Mutations in p53, p53 protein overexpression and breast cancer survival. J Cell Mol Med (2008) 0.96
GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Exp Ther Med (2012) 0.92
Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma. J Mol Diagn (2005) 0.92
DNA methylation changes in a human cell model of breast cancer progression. Mutat Res (2010) 0.91
Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study. Am J Clin Nutr (2011) 0.85
Recreational physical activity and steroid hormone levels in postmenopausal women. Am J Epidemiol (2009) 0.85
Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors. Cancer Epidemiol Biomarkers Prev (2015) 0.85
The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study. Epigenetics (2011) 0.84
The multiple promoter methylation profile of PR gene and ERalpha gene in tumor cell lines. Life Sci (2003) 0.84
The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence. Ann N Y Acad Sci (2004) 0.84
Molecular insights into the association of obesity with breast cancer risk: relevance to xenobiotic metabolism and CpG island methylation of tumor suppressor genes. Mol Cell Biochem (2014) 0.80